22 studies found for:    Open Studies | "Gout"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Gout"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Condition: Gout
Interventions: Drug: PF-06743649;   Other: Placebo
2 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
3 Recruiting Arthritis Research UK Gout Treatment Trial - Phase 2
Condition: Gout
Interventions: Other: Nurse intervention;   Other: Standard care
4 Not yet recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
5 Not yet recruiting RDEA3170 and Febuxostat Combination Study in Gout Subjects
Condition: Gout
Interventions: Drug: RDEA3170 15 mg;   Drug: RDEA3170 10 mg;   Drug: RDEA3170 2.5;   Drug: RDEA3170 5 mg;   Drug: Febuxostat 40 mg;   Drug: Febuxostat 80 mg
6 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
7 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Condition: Gout
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
8 Recruiting Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
Condition: Gout
Interventions: Drug: Arhalofenate 600 mg;   Drug: Allopurinol 300 mg;   Drug: Colchicine 0.6 mg;   Drug: Placebo;   Drug: Arhalofenate 800 mg
9 Recruiting Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
Conditions: Gout;   Hyperuricemia
Interventions: Drug: Arhalofenate;   Drug: Febuxostat;   Drug: Colchicine
10 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
Conditions: Gout;   Moderate Renal Impairment
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
11 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
12 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
13 Recruiting Rheumatology Informatics System for Effectiveness
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Gout
Intervention:
14 Recruiting Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
Intervention:
15 Unknown  Safety and Efficacy Study of Intramuscular Uricase-PEG 20
Conditions: Gout;   Hyperuricemia
Intervention: Biological: Uricase-PEG 20
16 Unknown  Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
17 Recruiting Hereditary Tubulointerstitial Nephritis
Conditions: Nephritis, Interstitial;   Chronic Renal Failure;   Gout;   Renal Cysts
Intervention: Other: Blood and urine sample collections
18 Recruiting Effects of Fasting on Self Efficacy
Conditions: Chronic Pain;   Fibromyalgia;   Rheumatoid Arthritis;   Gout;   Headache;   Arthritis;   Gastrointestinal Diseases;   Irritable Bowel Syndrome;   Inflammatory Bowel Disease;   Cardiovascular Diseases
Intervention: Behavioral: Fasting
19 Recruiting Mild, Moderate and Severe Renal Impairment Study
Condition: Gout
Intervention: Drug: RDEA3170
20 Recruiting Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Condition: Gouty Arthritis
Interventions: Drug: Canakinumab, ACZ885;   Drug: Triamcinolone acetonide

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years